Trueblood Wealth Management’s Perspective Therapeutics CATX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$238K	Buy	69,061 +46,825	+211%	+$161K	0.1%	222
2025 Q1	$47.4K	Hold	22,236	–	–	0.02%	234
2024 Q4	$70.9K	Buy	22,236 +6,000	+37%	+$19.1K	0.04%	225
2024 Q3	$217K	Buy	+16,236	New	+$217K	0.11%	216